Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Carcinoma, Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01767155
What this trial is testing

Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer

Who this might be right for
Endometrial Cancer
AEterna Zentaris 511
Testing effectiveness (Phase 2)Study completedNCT00267488
What this trial is testing

Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer

Who this might be right for
Neoplasms, EndometrialEndometrial Cancer
GlaxoSmithKline 70
Testing effectiveness (Phase 2)Ended earlyNCT05798611
What this trial is testing

Study of ART0380 in Patients With Biologically Selected Solid Tumors

Who this might be right for
Advanced Solid TumorRecurrent Endometrial CancerMetastatic Cancer
Artios Pharma Ltd 36
Testing effectiveness (Phase 2)Study completedNCT00005031
What this trial is testing

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT00977574
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 349
Testing effectiveness (Phase 2)Looking for participantsNCT06023862
What this trial is testing

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more
Yonsei University 198
Testing effectiveness (Phase 2)Study completedNCT03395080
What this trial is testing

DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma

Who this might be right for
Endometrial CancerUterine CancerOvarian Cancer+1 more
Leap Therapeutics, Inc. 111
Not applicableLooking for participantsNCT06890273
What this trial is testing

NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)

Who this might be right for
Endometrial Cancer
AstraZeneca 150
Not applicableEnded earlyNCT01271959
What this trial is testing

ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

Who this might be right for
Solid Organ Tumors
Precision Therapeutics 167
Testing effectiveness (Phase 2)Active Not RecruitingNCT05538897
What this trial is testing

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Who this might be right for
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaMetastatic Endometrial Endometrioid Adenocarcinoma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT01068249
What this trial is testing

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03348631
What this trial is testing

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Malignant Uterine Corpus NeoplasmRecurrent Ovarian Carcinoma+2 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT00334295
What this trial is testing

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Who this might be right for
Endometrial Carcinoma
AstraZeneca 35
Testing effectiveness (Phase 2)UnknownNCT00006903
What this trial is testing

Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7Stage IV Uterine Corpus Cancer AJCC v7
Gynecologic Oncology Group 67
Large-scale testing (Phase 3)Looking for participantsNCT07166094
What this trial is testing

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Who this might be right for
Endometrial CancerRecurrent or Progressive Endometrial Cancer
Genmab 660
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Testing effectiveness (Phase 2)UnknownNCT00003135
What this trial is testing

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+1 more
The University of Texas Health Science Center, Houston 34
Large-scale testing (Phase 3)Study completedNCT00063999
What this trial is testing

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage IIIA Uterine Corpus Cancer AJCC v7Stage IIIB Uterine Corpus Cancer AJCC v7+3 more
GOG Foundation 1,381
Early research (Phase 1)Study completedNCT00575952
What this trial is testing

Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+8 more
Gynecologic Oncology Group 27
Early research (Phase 1)Study completedNCT01256268
What this trial is testing

Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids

Who this might be right for
Endometrial CancerOvarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 24
Next Page
96